321 related articles for article (PubMed ID: 22798430)
1. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
[TBL] [Abstract][Full Text] [Related]
2. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
3. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
4. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
6. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
7. Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
Graves TG; Harr MW; Crawford EL; Willey JC
Mol Cancer; 2006 Jan; 5():1. PubMed ID: 16403226
[TBL] [Abstract][Full Text] [Related]
8. A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity.
Gasri-Plotnitsky L; Ovadia A; Shamalov K; Nizri-Megnaji T; Meir S; Zurer I; Cohen CJ; Ginsberg D
Oncotarget; 2017 Apr; 8(14):23775-23786. PubMed ID: 28423601
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of the CDK inhibitor p21
Kurayoshi K; Shiromoto A; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
Biochem Biophys Res Commun; 2017 Jan; 483(1):107-114. PubMed ID: 28042030
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
11. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.
Xu TP; Wang YF; Xiong WL; Ma P; Wang WY; Chen WM; Huang MD; Xia R; Wang R; Zhang EB; Liu YW; De W; Shu YQ
Cell Death Dis; 2017 Jun; 8(6):e2837. PubMed ID: 28569791
[TBL] [Abstract][Full Text] [Related]
12. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
Zhang M; Xu E; Zhang J; Chen X
Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
17. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.
Gizard F; Robillard R; Barbier O; Quatannens B; Faucompré A; Révillion F; Peyrat JP; Staels B; Hum DW
Mol Cell Biol; 2005 Jun; 25(11):4335-48. PubMed ID: 15899840
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
19. cGMP-independent nitric oxide signaling and regulation of the cell cycle.
Cui X; Zhang J; Ma P; Myers DE; Goldberg IG; Sittler KJ; Barb JJ; Munson PJ; Cintron Adel P; McCoy JP; Wang S; Danner RL
BMC Genomics; 2005 Nov; 6():151. PubMed ID: 16269079
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage.
Feldstein O; Nizri T; Doniger T; Jacob J; Rechavi G; Ginsberg D
Mol Cancer; 2013 Oct; 12(1):131. PubMed ID: 24168400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
